AU2003235095A1 - Piperidine derivatives - Google Patents

Piperidine derivatives

Info

Publication number
AU2003235095A1
AU2003235095A1 AU2003235095A AU2003235095A AU2003235095A1 AU 2003235095 A1 AU2003235095 A1 AU 2003235095A1 AU 2003235095 A AU2003235095 A AU 2003235095A AU 2003235095 A AU2003235095 A AU 2003235095A AU 2003235095 A1 AU2003235095 A1 AU 2003235095A1
Authority
AU
Australia
Prior art keywords
piperidine derivatives
piperidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003235095A
Inventor
Kaoru Hara
Tomio Yamakawa
Shinichi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Publication of AU2003235095A1 publication Critical patent/AU2003235095A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/30Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing heterocyclic ring with at least one nitrogen atom as ring member
AU2003235095A 2002-05-28 2003-04-23 Piperidine derivatives Abandoned AU2003235095A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-153988 2002-05-28
JP2002153988 2002-05-28
PCT/JP2003/005169 WO2003099788A1 (en) 2002-05-28 2003-04-23 Piperidine derivatives

Publications (1)

Publication Number Publication Date
AU2003235095A1 true AU2003235095A1 (en) 2003-12-12

Family

ID=29561337

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003235095A Abandoned AU2003235095A1 (en) 2002-05-28 2003-04-23 Piperidine derivatives

Country Status (3)

Country Link
JP (1) JPWO2003099788A1 (en)
AU (1) AU2003235095A1 (en)
WO (1) WO2003099788A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005030721A1 (en) * 2003-09-30 2005-04-07 Nippon Chemiphar Co., Ltd. Piperidine derivative
WO2012135669A1 (en) * 2011-04-01 2012-10-04 Weingarten M David Nitrogen ring containing compounds for treatment of inflammatory disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0482071B1 (en) * 1989-07-14 1998-01-07 Biodor U.S. Holding Corporation New antiviral agents
FR2655649B1 (en) * 1989-12-12 1994-07-08 Adir NOVEL PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TW198008B (en) * 1991-04-08 1993-01-11 Green Cross Corp

Also Published As

Publication number Publication date
WO2003099788A1 (en) 2003-12-04
JPWO2003099788A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
AU2003211362A1 (en) N-hydroxycarboxamide derivative
PL375220A1 (en) Piperidine derivatives
AU2003239909A1 (en) Enhanced-service provision
EP1682493B8 (en) Amidoacetonitrile derivatives
HK1072251A1 (en) Piperidine derivative
AU2003255492A1 (en) Heterocyclic derivatives
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
WO2003072535A8 (en) Substituted hydroxyethylamines
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003264753A1 (en) 1-sulphonyl piperidine derivatives
AU2003235913A1 (en) Cyanopyrrolidine derivatives
AU2003231388A1 (en) Novel piperidine derivative
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003902882A0 (en) Piperidyl derivatives
AU2003257637A1 (en) Proline derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase